Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petru Iulian Ifteni

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Therapeutics|October 7, 2025
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in AdultsAna Aliana Miron, Petru Iulian Ifteni, Timothy Nguyen, et al.
Frontiers in Pharmacology|August 4, 2025
Correction: The antipsychotics functional index (AFI) in schizophreniaGabriel-Cristian Marinescu, Petru Iulian Ifteni, Andreea Teodorescu, et al.
Frontiers in Pharmacology|July 17, 2025
The antipsychotics functional index (AFI) in schizophreniaGabriel-Cristian Marinescu, Petru Iulian Ifteni, Andreea Teodorescu, et al.
Schizophrenia (Heidelberg, Germany)|August 29, 2025
What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?Andreea-Violeta Popa, Petru Iulian Ifteni, Daniel Țâbian, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 30, 2018
C-Reactive Protein and T3: New Prognostic Factors in Acute Ischemic StrokeClaudia-Alexandrina Irimie, Mihai Vârciu, Marius Irimie, et al.
Medicina (Kaunas, Lithuania)|December 31, 2025
Trends in Sudden Death Among Schizophrenia InpatientsAndreea-Violeta Popa, Petru Iulian Ifteni, Paula Simina Petric, et al.
Aesthetic Surgery Journal. Open Forum|July 9, 2026
The Impact of Artificial Intelligence on Facial Aesthetic Surgery: A Systematic ReviewAurelia-Alexandra Colceriu, Petru-Iulian Ifteni, Liliana Rogozea, et al.
American Journal of Therapeutics|January 10, 2025
EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?Bogdan-Radu Necula, Radu Dan Necula, Paula Simina Petric, et al.
Medicina (Kaunas, Lithuania)|July 30, 2025
Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia PatientsAna-Aliana Miron, Petru Iulian Ifteni, Alexandra-Elena Lungu, et al.
American Journal of Therapeutics|March 3, 2020
A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer DementiaHoria Paunescu, Lorena Dima, Isabel Ghita, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Therapeutics|October 7, 2025
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in AdultsAna Aliana Miron, Petru Iulian Ifteni, Timothy Nguyen, et al.
Frontiers in Pharmacology|August 4, 2025
Correction: The antipsychotics functional index (AFI) in schizophreniaGabriel-Cristian Marinescu, Petru Iulian Ifteni, Andreea Teodorescu, et al.
Frontiers in Pharmacology|July 17, 2025
The antipsychotics functional index (AFI) in schizophreniaGabriel-Cristian Marinescu, Petru Iulian Ifteni, Andreea Teodorescu, et al.
Schizophrenia (Heidelberg, Germany)|August 29, 2025
What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?Andreea-Violeta Popa, Petru Iulian Ifteni, Daniel Țâbian, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 30, 2018
C-Reactive Protein and T3: New Prognostic Factors in Acute Ischemic StrokeClaudia-Alexandrina Irimie, Mihai Vârciu, Marius Irimie, et al.
Medicina (Kaunas, Lithuania)|December 31, 2025
Trends in Sudden Death Among Schizophrenia InpatientsAndreea-Violeta Popa, Petru Iulian Ifteni, Paula Simina Petric, et al.
Aesthetic Surgery Journal. Open Forum|July 9, 2026
The Impact of Artificial Intelligence on Facial Aesthetic Surgery: A Systematic ReviewAurelia-Alexandra Colceriu, Petru-Iulian Ifteni, Liliana Rogozea, et al.
American Journal of Therapeutics|January 10, 2025
EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?Bogdan-Radu Necula, Radu Dan Necula, Paula Simina Petric, et al.
Medicina (Kaunas, Lithuania)|July 30, 2025
Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia PatientsAna-Aliana Miron, Petru Iulian Ifteni, Alexandra-Elena Lungu, et al.
American Journal of Therapeutics|March 3, 2020
A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer DementiaHoria Paunescu, Lorena Dima, Isabel Ghita, et al.
Pageof 1